Remote Blood-Draw Dried-Spot Device Global Market Report 2025

The remote blood-draw dried-spot device market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth during the historic period can be attributed to the rising adoption of remote patient monitoring, the increasing prevalence of chronic diseases, the growing awareness of at-home diagnostic solutions, the expansion of home healthcare services, and the increasing demand for minimally invasive testing.

The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to the rising integration of artificial intelligence and digital tools, the growing focus on personalized medicine, the increasing government initiatives to enhance healthcare accessibility, the expansion of telemedicine networks, and the rising funding for diagnostic startups. Major trends during the forecast period include technological advancements in microfluidics, innovations in biosensor design, developments in automation and robotics, progress in data analytics integration, and innovations in patient-centric device interfaces.

The growing emphasis on personalized medicine is expected to drive the growth of the remote blood-draw dried-spot device market in the coming years. Personalized medicine involves tailoring medical treatments and preventive strategies based on an individual’s unique genetic, molecular, and clinical characteristics to achieve better health outcomes. The adoption of personalized medicine is increasing as advances in genomics make it possible to identify genetic variations that influence disease susceptibility and treatment response, enabling more targeted and effective therapies. Remote blood-draw dried-spot devices support this approach by allowing convenient, at-home collection of small blood samples, facilitating frequent monitoring of biomarkers and genetic information to guide individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer therapies and three for other conditions. Therefore, the rising focus on personalized medicine is driving the growth of the remote blood-draw dried-spot device market.

Major companies in the remote blood-draw dried-spot device market are developing advanced decentralized sampling solutions to enable at-home blood collection, enhance patient convenience, and improve clinical trial efficiency. Decentralized sampling involves collecting biological samples outside traditional clinical settings, such as at home or in local facilities, allowing broader participation, faster sample turnaround, and improved data accessibility. For example, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced next-generation dried blood spot (DBS) sampling technology designed for clinical trials and sports anti-doping testing. This innovation provides a virtually painless, accurate, and user-friendly method for blood collection, enabling precise volumetric sampling and high-quality data generation. By simplifying the sampling process and reducing participation barriers, the technology enhances compliance, accelerates drug development, and supports decentralized healthcare and research models.

In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. The collaboration aims to transform home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based sampling and drug delivery patches. This combined digital health platform enables precise, continuous, and patient-friendly diagnostics and therapeutics, promoting the shift from clinic-centered to decentralized personalized care. Nanowear Inc., a US-based technology company, offers remote blood-draw dried-spot devices that complement these innovations in wearable biosensing and digital health monitoring.

Major players in the remote blood-draw dried-spot device market are DBS System SA, Labcorp Holdings, Thorne HealthTech Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Tasso Inc., Lipomic Healthcare Inc., Neoteryx Inc., Salimetrics LLC, Eastern Business Forms Inc., Ash Wellness Inc., Capitainer AB, Drawbridge Health Inc., HemaXis S.A., ImmunoServ Ltd., Labonovum BV, PanoHealth Inc., RedDrop Dx Inc., Nightingale Health Plc, Spot On Sciences Inc., and RDA Spot Inc.

North America was the largest region in the remote blood-draw dried-spot device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote blood-draw dried-spot device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The remote blood-draw dried-spot device market research report is one of a series of new reports that provides remote blood-draw dried-spot device market statistics, including remote blood-draw dried-spot device industry global market size, regional shares, competitors with a remote blood-draw dried-spot device market share, detailed remote blood-draw dried-spot device market segments, market trends and opportunities, and any further data you may need to thrive in the remote blood-draw dried-spot device industry. This remote blood-draw dried-spot device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A remote blood draw dried spot device is a medical tool used to collect small blood samples from patients remotely, often in home settings, by applying the blood onto specialized filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for testing, allowing convenient monitoring of health parameters without the need for traditional venous blood draws.

The main product types of remote blood draw dried spot devices include filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, providing a convenient, stable, and easily transportable method for dried blood spot testing. The supported sample types include whole blood, plasma, serum, and others, and these products are distributed through direct sales, online retail, pharmacies, and other channels. They are used in various applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, and serve end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.

The countries covered in the remote blood-draw dried-spot device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.